Showing 131-140 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
Preclinical Optimization of Polyclonal IgM for Type 1 Diabetes Prevention and Reversal Rector & Visitors of the University of Virginia Kenneth Brayman Cures 01-July-2024 to 30-June-2025 $249.500,00
Role of β-cell Golgi dysfunction in Type 1 diabetes pathogenesis The University of Iowa Samuel Stephens Cures 01-June-2024 to 31-May-2027 $750.000,00
Assessing and mitigating T cell recognition of iPSC derived endocrine cells in Type 1 Diabetes Benaroya Research Institute at Virginia Mason Eddie James Cures 01-June-2024 to 31-May-2026 $500.000,00
Local bioelectronic oxygenation for islet engraftment Carnegie Mellon University Tzahi Cohen-Karni Cures 01-August-2024 to 31-July-2027 $974.998,74
Improving pig islet transplant efficacy in a preclinical baboon diabetes model with induced immune tolerance to the xenografts Trustees of Columbia University in the City of New York Megan Sykes Cures 01-June-2024 to 31-May-2026 $599.999,94
Preclinical development of the BMP receptor agonist THR-184 for beta cell regeneration University of Miami Juan Dominguez-Bendala Cures 01-April-2024 to 31-March-2027 $741.000,00
Combinational immune therapies with antigen-specific Tregs for tolerance induction in islet transplantation University of Florida Allison Bayer Cures 01-September-2023 to 30-September-2025 $510.297,39
Building the Evidence to Address Disparities in Young children with Type 1 Diabetes: BEADY-T1D Stanford University Ananta Addala Improving Lives 01-February-2025 to 31-January-2029 $943.983,20
Pro-Angiogenic and Immune-Modulatory Scaffolds for the Functional Engraftment of Islets in the Subcutaneous Space Carnegie Mellon University Adam Feinberg Cures 01-November-2024 to 31-October-2027 $950.000,00
Enhancing Human Stem Cell-Derived Islet Survival and Function Using SA-PD-L1-Presenting Microgels Washington University Jeffrey Millman Cures 01-August-2024 to 31-July-2027 $1.125.000,00